Max Healthcare Institute Ltd

Large Cap

Healthcare Sector

reflects a positive outlook for the share price

reflects a neutral outlook for the share price

reflects a negative outlook for the share price

The analysts information is for reference only and does not\n  represents an investment recommendation.

Analyst recommendation reflect the views of analysts who follow and write research reports.

Company Information is an introduction to the company’s business that details what it sell, how it was founded, what their mission is, how they manufacture or source their products, and why they serve customers.

Jefferies names Max Healthcare as a top pick, forecasting accelerated growth with plans to add 4,700 beds and a projected revenue of Rs 1,38,000 crore by FY28. The brokerage expects strong EBITDA growth and maintains a Buy rating.

Jefferies Highlights Max Healthcare's Growth Potential - 09 Oct, 2025

Max Healthcare Institute Ltd reported consolidated sales of Rs 20,276 million and a net profit of Rs 3,080 million in Q1 FY26, reflecting substantial growth. Additionally, Nuvama estimates a revenue boost and margin expansion from CGHS repricing.

Max Healthcare Reports Strong Q1 Growth - 08 Oct, 2025

Max Healthcare anticipates a revenue increase of 4-8% and margin growth due to new CGHS rates. Additionally, no demat requests indicate stability in shareholding.

Max Healthcare Sees Revenue Boost from CGHS Rate Changes - 07 Oct, 2025

Max Healthcare Institute Ltd experienced significant gains on October 6, 2025, following the government's revision of rates under the Central Government Health Services scheme, leading to improved cash flows and margins for the company.

Max Healthcare Stock Surges After CGHS Rate Revisions - 06 Oct, 2025

Max Healthcare Institute Ltd's management forecasts 3-7% ARPOB growth, emphasizing oncology and international patients. CARE Ratings reaffirmed its credit rating amid merger plans for Crosslay Remedies.

Max Healthcare's Growth Guidance and Credit Rating Reaffirmed - 02 Oct, 2025

Max Healthcare is joining the Nifty 50, prompting significant buying from both passive and active funds. Analysts are bullish on its growth potential, with strong expansion plans and a positive outlook on its diagnostics and home care businesses. The stock is expected to attract substantial demand due to its underweight status among active funds, with a projected revenue CAGR of 20% over FY25-28E.

Max Healthcare Set for Nifty 50 Inclusion - 29 Sep, 2025

Price to Earnings Ratio or Price to Earnings Multiple is the ratio of the share price of a stock to its earnings per share (EPS). It provides an indication of whether a stock at its current market price is expensive or cheap.

The price/earnings-to-growth ratio, or the PEG ratio, is a metric that helps investors value a stock by taking into account a company's market price, its earnings, and its future growth prospects.

Enterprise value (EV) is the total value of a company, defined in terms of its financing. It includes both the current share price (market capitalization) and the cost to pay off debt (net debt, or debt minus cash).

Alpha measures the amount that the investment has returned in comparison to the market index or other broad benchmark that it is compared against.

Beta measures a stock's volatility, the degree to which its price fluctuates in relation to the overall stock market. In other words, it gives a sense of the stock's risk compared to that of the greater market.

Dividend yield measures the quantum of earnings by way of total dividends that investors make by investing in that company.

The debt-to-total-assets ratio shows how much of a business is owned by creditors (people it has borrowed money from) compared with how much of the company's assets are owned by shareholders.

Operating cash flow (OCF) is a measure of the amount of cash generated by a company's normal business operations. Operating cash flow indicates whether a company can generate sufficient positive cash flow to maintain and grow its operations.

This widget shows the information about the stock's peers in consideration along with the different data for those peers so that the user can compare the stock with the other similar stock and invest accordingly.

Promoter holding is the amount of share of the company that is owned by the promoters. The promoters are the company's founders, who hold a majority stake in the company's capital.

A foreign institutional investor (FII) is an investor or investment fund investing in a country outside of the one in which it is registered or headquartered.

A mutual fund is a pool of money managed by a professional Fund Manager. It is a trust that collects money from a number of investors who share a common investment objective and invests the same in equities, bonds, money market instruments, and other securities.

Retail investors execute their trades through traditional or online brokerage firms or other types of investment accounts. Retail investors purchase securities for their own personal accounts and often trade in dramatically smaller amounts as compared to institutional investors.

This widget shows the bifurcation of stocks based on the percentage of stake with the different types of shareholders.

This widget will help value the stock based on the Price to Earning ratio of the stock and compare the valuation with the industry value and other similar stocks. It even shows the timeline of the valuation of the stock and its highest and lowest valuation over time.
A Time Series data is provided which compares the historical stock PE with Industry PE over the period of 5 years.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

Mutual Funds have increased holdings from 12.54% to 14.25% in Sep 2025 quarter

This section gives you an insight into how the Mutual Funds Holding has changed for the stock over last few quarters.

MF Holding Up

Revenue is up for the last 7 quarters, 1.38K Cr → 2.06K Cr (in ₹), with an average increase of 6.5% per quarter

This section gives you an insight into how the revenue of the company has moved for the last few quarters.

Revenue Rich

Retail Investor have increased holdings from 4.08% to 4.43% in Sep 2025 quarter

This section gives you an insight into how the Retail Investors Holding has changed for the stock over last few quarters.

Retail Holding Up

Promoters holdings remained unchanged at 23.74% of holdings in Sep 2025 quarter

This section gives you an insight into how the Promoter Holding has changed for the stock over the last few quarters.

Promoter Holding Unchanged

In the last 3 years, Fortis Healthcare Ltd has given 265.0% return, outperforming this stock by 117.4%

This section gives you an insight into how the peers have performed as compared to this company in the last 3 years.

Against Peers

In the last 1 year, Fortis Healthcare Ltd has given 62.3% return, outperforming this stock by 51.8%

This section gives you an insight into how the peers have performed as compared to this company in the last 1 year.

In the last 7 days, MAXHEALTH stock has moved down by -2.9%

This section gives you an insight into the price movement of the stock for the last few quarters.

Price Dip

Foreign Institutions have decreased holdings from 54.76% to 51.80% in Sep 2025 quarter

This section gives you an insight into how the FII Holding has changed for the stock over last few quarters.

FII Holding Down

Netprofit is down for the last 2 quarters, 319.0 Cr → 307.97 Cr (in ₹), with an average decrease of 3.5% per quarter

This section gives you an insight into how the profit for the company has been for the last few quarters.

Profit Down

Nifty Infra

Nifty100 Eq Weig

Nifty India Consumption

S&P BSE Largecap

BSE 100

Nifty Healthcare

S&P BSE SEN. N50

S&P BSE Momentum

NIFTY 100

S&P BSE 100 ESG

NIFTY 50

S&P BSE 100 LargeCap TMC

Nifty 200

S&P BSE 250 LargeMidCap

BSE 200

Nifty Alpha 50

Nifty Services Sector

Nifty 500

BSE Healthcare

Nifty LargeMidcap 250

BSE 500

SBI Equity Hybrid Fund Direct Growth

Nippon India Growth Mid Cap Fund - Direct Plan - Growth Mid Cap

Kotak Midcap Fund Direct Growth

Kotak Arbitrage Fund Direct Growth

Motilal Oswal Midcap Direct Growth

Max Healthcare Institute Ltd’s net profit jumped 30.35% since last year same period to ₹307.97Cr in the Q1 2025-2026. On a quarterly growth basis, Max Healthcare Institute Ltd has generated -3.46% fall in its net profits since last 3-months.

Max Healthcare Institute Ltd Earnings Results

In the quarter ending March 2025, Max Healthcare Institute Ltd has declared dividend of ₹1.50 per share on 20 May 2025 - translating a dividend yield of 0.26%.

Name	Value	Action
MACD level (12,26)	1.05	Bullish
CCI (20)	229.14	Bearish
RSI (14)	69.85	Neutral
Momentum (10)	2.1	Bearish
ADI (14)	37.04	Bullish
Ultimate Oscillator (7,14,28)	42.97	Neutral

Name	Value	Action
SMA (20)	1139.24	Bullish
EMA (20)	1139.23	Bullish
VWMA (20)	1139.76	Bullish
SMA (50)	1136.73	Bullish
EMA (50)	1138.22	Bullish
SMA (200)	1141.72	Bearish
EMA (200)	1140.71	Bullish
KAMA (200)	1136.69	Bullish
DEMA (200)	1137.73	Bullish

Max Healthcare Institute Ltd (MAXHEALTH)

Summary

Overall

Oscillators

Moving Averages